RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 1-11
  • Seasonal Allergies

    Seasonal Allergies
    It just might be the only unwelcome sign of spring: Seasonal Allergies. The sniffling, sneezing and burning eyes are back. "The pollen count is higher than normal this year, mainly because of the prolonged cold we had in the winter", says FOXCT...
  • Childhood Vaccinations

    Childhood Vaccinations
    The decision to vaccinate your children: a parents choice or public health risk? Last week, reality TV star Kristin Cavallari talked about about how she and her husband weren't vaccinating their children because she said, "I've read too many books about...
  • Raising Awareness About Morning Sickness Medication

    Raising Awareness About Morning Sickness Medication
    Reports of Kate Middleton's severe morning sickness opened eyes about how hard pregnancy can be for some women.  "I went to the emergency room because I was so sick and dehydrated after a week of not being able to eat or drink," says Megan Donofrio of...
  • News of the Weird: Norway's Battle Against Chaos

    News of the Weird: Norway's Battle Against Chaos
    Norwegian public television (NRK), which introduced the now-legendary continuous, live log-burning show (12 hours long, with “color commentary” on the historical and cultural importance of fire), scheduled a new program for this week in its...
  • Alexion Pharmaceuticals Names New CEO

    Alexion Pharmaceuticals Names New CEO
    Alexion Pharmaceuticals Inc. in Cheshire has named a new chief executive, David L. Hallal, to replace current CEO and company founder Dr. Leonard Bell, effective April 1. Bell will continue to serve as chairman of the board of directors, the company...
  • AbbVie posts 4Q loss on Shire deal breakup fee but adjusted results top expectations on Humira

    Drugmaker Abbvie posted better-than-expected adjusted results for the fourth quarter on Friday due to double-digit growth of its blockbuster anti-inflammatory drug Humira. Sales of Humira increased 10.6 percent to $3.36 billion, offsetting lower sales of...
  • AbbVie's breakup with Shire torpedoes 4th quarter, 2014 results

    AbbVie's breakup with Shire torpedoes 4th quarter, 2014 results
    AbbVie's fourth-quarter and 2014 earnings were defined by an engagement to Irish drugmaker Shire that quickly crumbled. The North Chicago-based biopharmaceutical spinoff from Abbott Laboratories beat expectations on adjusted figures but took a blow...
  • Baxter's 2014 earnings: 4th quarter beat expectations

    Baxter's 2014 earnings: 4th quarter beat expectations
    Baxter International, the Deerfield-based medical products and pharmaceutical company, reported full year 2014 earnings Thursday as well as fourth-quarter results. The company beat expectations in nearly every category. Here's how the quarter and year...
  • Abbott ends 2014 'with good momentum'

    Abbott ends 2014 'with good momentum'
    Abbott Laboratories, a North Chicago-based pharmaceutical and health care products company, reported full year 2014 earnings on Thursday, as well as fourth-quarter results. Abbott performed well overall, with the year marked by sales and acquisitions....
  • Drugmaker Pfizer's 4Q profit plunges on lower sales, higher research, legal and other costs

    Pfizer Inc.'s fourth-quarter profit fell by half as worsening generic competition and unfavorable currency rates reduced sales, and higher research spending and legal costs also hurt the bottom line. The world's second-biggest drugmaker by revenue...
  • Hogan's budget includes some cuts, some status quo for economic development programs

    Hogan's budget includes some cuts, some status quo for economic development programs
    Advocates for programs spending state dollars on stem cell research or investment in technology companies were nervous about what Gov. Larry Hogan's budget would hold for them, given warnings of "strong medicine" to cure fiscal woes. But after Hogan's...